Journal of the Korean Ophthalmological Society 2005;46(2):237-242.
Published online February 28, 2005.
Tear Film and Ocular Surface Changes after Umbilical Cord Serum Therapy in Dry Eye Syndrome.
Kyung Chul Yoon, Seong Kyu Im, Yeoung Geol Park, Jin Choi
1Department of Ophthalmology, Chonnam University Medical School and Hospital, Gwang-Ju, Korea. kcyoon@chonnam.ac.kr
2Department of Obstetrics and Gynecology, Eun Hospital, Gwang-ju, Korea.
안구건조증 환자에서 제대혈청 점안액 치료 후 눈물막 및 안구표면의 변화
윤경철1,임성규1,박영걸1,최진2
Department of Ophthalmology, Chonnam University Medical School & Hospital1, Gwang-Ju, Korea Department of Obstetrics and Gynecology, Eun Hospital2, Gwang-ju, Korea
Correspondence:  Kyung-Chul Yoon, M.D.1
Abstract
PURPOSE
To evaluate the changes of tear film and ocular surface after umbilical cord serum therapy in patients with severe dry eye syndrome. METHODS: Forty-one eyes of 25 patients with severe dry eye syndrome were treated with umbilical cord serum eyedrops. Before and after treatment, symptom score, tear film break-up time (BUT), Schirmer test, corneal sensitivity, keratoepitheliopathy score, and impression cytology were performed. RESULTS: Before treatment, symptom score, BUT, Schirmer test, corneal sensitivity, and keratoepitheliopathy score were 3.18 +/- 0.50, 3.50 +/- 1.27 sec, 3.24 +/- 0.94 mm, 51.63 +/- 9.29 mm, and 6.13 +/- 2.85, respectively. Two months after treatment, the respective parameters were 1.03 +/- 0.53 (P<0.001), 5.42 +/- 2.79 sec (P<0.001), 3.42 +/- 1.16 mm (P=0.067), 52.87 +/- 7.92 mm (0.071), and 2.10 +/- 1.98 (P<0.001). In impression cytology, the grade of squamous metaplasia and goblet cell density were 2.44 +/- 0.71 and 75.05 +/- 41.81 cells/mm2 before treatment, and 1.47 +/- 0.62 and 165.48 +/- 39.19 cells/mm2 at 2 months after treatment, respectively (P<0.001). CONCLUSIONS: Umbilical cord serum treatment is clinically applicable and effective in patients with severe dry eye syndrome.
Key Words: Dry eye syndrome;Impression cytology;Umbilical cord serum


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next